177 related articles for article (PubMed ID: 36765641)
1. Generation of Stable Epithelial-Mesenchymal Hybrid Cancer Cells with Tumorigenic Potential.
Tedja R; Alvero AB; Fox A; Cardenas C; Pitruzzello M; Chehade H; Bawa T; Adzibolosu N; Gogoi R; Mor G
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765641
[TBL] [Abstract][Full Text] [Related]
2. Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas.
Jolly MK; Somarelli JA; Sheth M; Biddle A; Tripathi SC; Armstrong AJ; Hanash SM; Bapat SA; Rangarajan A; Levine H
Pharmacol Ther; 2019 Feb; 194():161-184. PubMed ID: 30268772
[TBL] [Abstract][Full Text] [Related]
3. lncRNA HOTAIR overexpression induced downregulation of c-Met signaling promotes hybrid epithelial/mesenchymal phenotype in hepatocellular carcinoma cells.
Topel H; Bagirsakci E; Comez D; Bagci G; Cakan-Akdogan G; Atabey N
Cell Commun Signal; 2020 Jul; 18(1):110. PubMed ID: 32650779
[TBL] [Abstract][Full Text] [Related]
4. LY75 Suppression in Mesenchymal Epithelial Ovarian Cancer Cells Generates a Stable Hybrid EOC Cellular Phenotype, Associated with Enhanced Tumor Initiation, Spreading and Resistance to Treatment in Orthotopic Xenograft Mouse Model.
Mehdi S; Macdonald E; Galpin K; Landry DA; Rodriguez G; Vanderhyden B; Bachvarov D
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32679765
[TBL] [Abstract][Full Text] [Related]
5. Stability of the hybrid epithelial/mesenchymal phenotype.
Jolly MK; Tripathi SC; Jia D; Mooney SM; Celiktas M; Hanash SM; Mani SA; Pienta KJ; Ben-Jacob E; Levine H
Oncotarget; 2016 May; 7(19):27067-84. PubMed ID: 27008704
[TBL] [Abstract][Full Text] [Related]
6. A Computational Systems Biology Approach Identifies SLUG as a Mediator of Partial Epithelial-Mesenchymal Transition (EMT).
Subbalakshmi AR; Sahoo S; Biswas K; Jolly MK
Cells Tissues Organs; 2022; 211(6):689-702. PubMed ID: 33567424
[TBL] [Abstract][Full Text] [Related]
7. Comparative Study of Transcriptomics-Based Scoring Metrics for the Epithelial-Hybrid-Mesenchymal Spectrum.
Chakraborty P; George JT; Tripathi S; Levine H; Jolly MK
Front Bioeng Biotechnol; 2020; 8():220. PubMed ID: 32266244
[TBL] [Abstract][Full Text] [Related]
8. NFATc Acts as a Non-Canonical Phenotypic Stability Factor for a Hybrid Epithelial/Mesenchymal Phenotype.
Subbalakshmi AR; Kundnani D; Biswas K; Ghosh A; Hanash SM; Tripathi SC; Jolly MK
Front Oncol; 2020; 10():553342. PubMed ID: 33014880
[TBL] [Abstract][Full Text] [Related]
9. Co-expression of hepatocyte growth factor and c-Met predicts peritoneal dissemination established by autocrine hepatocyte growth factor/c-Met signaling in gastric cancer.
Toiyama Y; Yasuda H; Saigusa S; Matushita K; Fujikawa H; Tanaka K; Mohri Y; Inoue Y; Goel A; Kusunoki M
Int J Cancer; 2012 Jun; 130(12):2912-21. PubMed ID: 21796631
[TBL] [Abstract][Full Text] [Related]
10. Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells.
Kröger C; Afeyan A; Mraz J; Eaton EN; Reinhardt F; Khodor YL; Thiru P; Bierie B; Ye X; Burge CB; Weinberg RA
Proc Natl Acad Sci U S A; 2019 Apr; 116(15):7353-7362. PubMed ID: 30910979
[TBL] [Abstract][Full Text] [Related]
11. EBV latent membrane proteins promote hybrid epithelial-mesenchymal and extreme mesenchymal states of nasopharyngeal carcinoma cells for tumorigenicity.
Zhu N; Xu X; Wang Y; Zeng MS; Yuan Y
PLoS Pathog; 2021 Aug; 17(8):e1009873. PubMed ID: 34407150
[TBL] [Abstract][Full Text] [Related]
12. Epithelial, mesenchymal and hybrid epithelial/mesenchymal phenotypes and their clinical relevance in cancer metastasis.
Garg M
Expert Rev Mol Med; 2017 Mar; 19():e3. PubMed ID: 28322181
[TBL] [Abstract][Full Text] [Related]
13. Emerging Concepts of Hybrid Epithelial-to-Mesenchymal Transition in Cancer Progression.
Sinha D; Saha P; Samanta A; Bishayee A
Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33207810
[TBL] [Abstract][Full Text] [Related]
14. The Quasimesenchymal Pancreatic Ductal Epithelial Cell Line PANC-1-A Useful Model to Study Clonal Heterogeneity and EMT Subtype Shifting.
Ungefroren H; Thürling I; Färber B; Kowalke T; Fischer T; De Assis LVM; Braun R; Castven D; Oster H; Konukiewitz B; Wellner UF; Lehnert H; Marquardt JU
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565186
[TBL] [Abstract][Full Text] [Related]
15. Epithelial-to-Mesenchymal Transition in the Light of Plasticity and Hybrid E/M States.
Bornes L; Belthier G; van Rheenen J
J Clin Med; 2021 May; 10(11):. PubMed ID: 34072345
[TBL] [Abstract][Full Text] [Related]
16. Network topology metrics explaining enrichment of hybrid epithelial/mesenchymal phenotypes in metastasis.
Rashid M; Hari K; Thampi J; Santhosh NK; Jolly MK
PLoS Comput Biol; 2022 Nov; 18(11):e1010687. PubMed ID: 36346808
[TBL] [Abstract][Full Text] [Related]
17. Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis.
Jolly MK; Boareto M; Huang B; Jia D; Lu M; Ben-Jacob E; Onuchic JN; Levine H
Front Oncol; 2015; 5():155. PubMed ID: 26258068
[TBL] [Abstract][Full Text] [Related]
18. Quantifying Cancer Epithelial-Mesenchymal Plasticity and its Association with Stemness and Immune Response.
Jia D; Li X; Bocci F; Tripathi S; Deng Y; Jolly MK; Onuchic JN; Levine H
J Clin Med; 2019 May; 8(5):. PubMed ID: 31121840
[TBL] [Abstract][Full Text] [Related]
19. Re-evaluating the role of epithelial-mesenchymal-transition in cancer progression.
Sulaiman A; Yao ZM; Wang LS
J Biomed Res; 2018 Mar; 32(2):81-90. PubMed ID: 28546516
[TBL] [Abstract][Full Text] [Related]
20. Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance.
Kim YJ; Choi WI; Jeon BN; Choi KC; Kim K; Kim TJ; Ham J; Jang HJ; Kang KS; Ko H
Toxicology; 2014 Aug; 322():23-33. PubMed ID: 24793912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
